For those who, loved one, or a friend are looking into submitting claims from the diabetes medication Onglyza (saxagliptin) for inducing health complications which have heart failure or departure, then we are more than happy to provide you with the help your Onglyza lawsuit deserves.
AstraZeneca is the business that makes Onglyza, an FDA-approved medication meant to treat type 2 diabetes.
The FDA (Food and Drug Administration) states that Onglyza users may have a substantial risk of developing congestive heart failure. In a recent FDA advisory committee meeting, it had been passed that the tagging used on Onglyza be upgraded with clear warnings about the risk of developing heart failure. It was a warning that was not contained the drug’s labels before.
For those who, loved one, or relative took Onglyza and endured heart failure, or your loved one died, you might have grounds for requesting compensation against the manufactures of Onglyza. Know that AstraZeneca is a massive company and has a group of trusted Mass Tort attorneys representing its own interests when the company is slapped with lawsuits.
Get in contact with our class-action lawyers to get a free consultation, case review, and to learn more about your rights.
Januvia is another drug, such as Onglyza, that is used as a treatment for type 2 diabetes. With the rise in insulin levels, the body can process glucose (sugars) and ensure they are maintained within the normal range.
FDA approved using Onglyza after reviewing the outcomes of eight clinical trials achieved by producers AstraZeneca Pharmaceuticals LP. The trial included safety study meant to demonstrate that Onglyza was not associated with any significant risk of cardiovascular complications.
However, recent analyses of the results of a clinical trial on Onglyza done by FDA experts found that concerning issues that linked the medicine to heart disease risks. The trial (the SAVOR research ), that was sponsored by AstraZeneca, had more than 16,000 participants. The participants had a history or prone to developing cardiovascular disease. Some of these were given Onglyza, and others obtained Placebo.
The researchers tracked the participants’ health advancement for approximately two years. The results showed a number of the patients that utilized Onglyza were hospitalized for heart failure than those who got Placebo. The Onglyza users possess a 27% higher risk of cardiovascular disease, heart failure, or related complications.
The results required stricter scrutiny on the drug by the FDA.
Is Onglyza Linked To Heart Failure?
Cardiovascular disease is one of the top health problems that result in the death of both men and women in the USA. The CDC claims there are almost 610,000 fatalities attributed to heart disease annually.
It is a kind of cardiovascular disease where the body receives an inadequate supply of blood. Thus, less oxygen into its organs, thus crippling their collective purpose. If not treated, heart failure grows and results in deadly health issues with fatal consequences.
For people who have type 2 diabetes and are using Onglyza, the link between their health issues and the drug is alarming. The FDA started an investigation process into the medication and how it increases the probability of heart failure; this is after grown concerns across the United States. The analysis unearthed worrying problems that led to additional warnings of heart failure risk linked with the usage of Onglyza in addition to Kombiglyze XR.
Is There A Link Between Onglyza And Pancreatic Cancer?
Because of how Onglyza stimulates the pancreas to release insulin, that’s the reason the medication was associated with the consumers confronting a prospective gain in the risk of pancreatitis and pancreatic cancer.
A study was done in 2013 that focused on how DDP-4 inhibitors affected the pancreas found that participants who had type 2 diabetes and were using Onglyza have a greater chance of having an enlarged pancreas. They also have an elevated risk of having precancerous cellular changes in their own pancreas, suggesting a significant probability of developing pancreatic cancer. According to the study, it was also discovered that tumors (precancerous growths) are highly likely to require surgical interventions also that the patients using medication such as Onglyza showed a greater risk of desire pancreatic surgery.
The FDA communicated another drug safety awake in March of 2013, stating it was examining findings of a research that indicated the substantial probability of pancreatitis and precancerous cellular changes people which were utilizing incretin mimetic to take care of their own type 2 diabetes.
A later study conducted in 2014 where researchers analyzed data from a significant clinical trial on Onglyza discovered no indications of pancreatic cancer or the possibility of pancreatitis. They, nevertheless, recommended further research to ensure they get conclusive findings which suggest pancreatic safety regarding the use of incretin mimetics.
Is Onglyza Linked To Thyroid Cancer?
Victoza, an incretin mimetic that shares similarities with Onglyza, was found to cause malignant thyroid gland as well as severe pancreatitis in rodents that were given the drug in”clinically relevant” dosages. In June 2011, the FDA issued a safety warning saying the risk of thyroid cancer from the use of Victoza. Furthermore, the FDA has received several reports of individuals diagnosed with thyroid cancer after using prescribed incretin mimetics such as Byetta (exenatide) and Januvia (sitagliptin).
No recall was announced, and it’s unlikely for you to be issued anytime soon. The recalls seem unforthcoming, yet the reality of heart failure, cancers, and other potentially fatal health issues can’t be overlooked or swept under the rug. Vioxx was a medicine that was recalled because of causing strokes and heart attacks, among other cardiovascular problems. The same fate is due to Onglyza along with other incretin mimetics found to increase the risk of heart failure. However, it appears that the only important step taken for these medications with such serious side effects would be to require that the producers incorporate extra safety warnings on their products’ labels.
Are There Any Active Class Action Lawsuits Involving Kombiglyze, Onglyza, Or Any Other Incretin Mimetic?
Drug harm lawsuits are seldom filed as”class action,” where a few plaintiffs will represent the others that have instances against a drug business. Alternatively, you can fill such a matter individually.
Back in January 2018, the U.S Judicial Panel on Multidistrict Litigation ordered the”consolidation” of existing lawsuits filed from Kombiglyze and Onglyza from the U.S District Court for the Eastern District of Kentucky. By May 2018, there were approximately 100 of those cases that shaped consolidated litigation called the MDL 2809.
Some of the most notable negative health problems associated with the use of Onglyza include:
- Heart failure
- Kidney problems
- Thyroid cancer
- Pancreatic cancer
Aside from the acute side effects mentioned above, Onglyza is also connected to the next moderate to moderate health risk:
- Urinary tract infections
- Rashes and Infection
Can You File A Lawsuit Against Onglyza If It Hasn’t Been Recalled?
However, this directive has many asking why the warning was never included when the item was released ten years back.
And when this is the present condition of affairs, then it means lots of the patients that took Onglyza within the last decade were unaware of the potential health risk.
The legislation stipulates that drug makers must be responsible for ensuring that the public is duly informed before they release a product into the industry. It makes them liable for any negative outcomes and serves to protect the public from unnecessary health problems.
And as per the legislation, patients who took Onglyza and endured heart failure can seek reimbursement since the pharmaceutical companies making the medication fail to provide the public with sufficient security warnings about such a probable outcome.
Contact Our Attorneys To File An Onglyza Lawsuit
If you or a loved one used Onglyza and endured heart failure, hospitalization, or your relative died because of using the medication, our dedicated class action lawyers are here to help. We’ve represented different people from throughout the nation. Therefore, we have a deep comprehension o how pharmaceuticals like Bristol Meyers Squibb and AstraZeneca are anticipated, by legislation, to ensure physicians and patients are fully conscious of the risk associated with the usage of their medications. Failure to do this means that these producers are liable for harm people who use their drugs suffer.
We have dealt with cases related to Onglyza and also have a profound understanding of its own flaws. Therefore, we are your best option if you would like to face the manufacturers of Onglyza and win. Contact our law offices now at 855-938-0980 a free consultation, case review, and find out more about your rights.